In addition, treatment of LY294002 on the cells blocked activation of PI3K/AKT, Cyclin D1 and E2F1 due to the knockdown of RGS4 in melanoma cells and consequently decreased the expression of p-Akt, Cyclin D1 and E2F1. Here, AKT1 is linked to melanoma.